Category Archives: Uncategorized

Drug Industry Influence on Medical Journals and Medical Research

Nearly a year and a half ago, we covered the topic of drug industry influence on medical journals and research. The lead story in yesterday's Washington Post treats the topic in detail, noting that even the most prestigious medical journals have trouble avoiding bias in favor of the industry. The Post piece focuses on a […]

Massive New England Journal Study of Mammagrophy Sure to Provoke Controversy

This three-decade study of the effectiveness of mammography to screen for breast cancer is sure to provoke controversy. Mammography has detected many breast cancers and saved lives, but, the study says, mammography over-diagnoses — that is, in many circumstances, it purports to find problems that never would have progressed to clinical breast cancer. Here is […]

Feds Seek Dismissal of Suit Challenging Dodd-Frank and the CFPB

Last June, we told you about a federal-court suit filed by a Texas Bank, the Competitive Enterprise Institute, and the 60 Plus Association challenging various provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the constitutionality of the Consumer Financial Protection Bureau. Here is the complaint. The federal government has now moved […]

More on George Will’s Criticism of the CFPB, and a Defense of the CFPB’s Use of Its Anti-Abuse Authority

Recently, on this blog, Jeff Sovern went after George Will's attack on the Consumer Financial Protection Bureau, rightly noting that the CFPB's exercise of its regulatory and enforcement powers generally are not terribly different from what regulatory agencies have been doing for decades. Now, Jean Braucher has posted this extensive response to Will's piece. In doing […]

Ingorance About Obamacare Could Jeopardize Its Effectiveness

Keeping health care costs down under the Affordable Care Act depends significantly on increasing particiption in private health care plans (which, if the Act works as contemplated, would be spurred in part by subsidies provided under the law). As explained in this article by Sarah Kliff, because many people do not know about the law's […]

FTC and CFPB join forces to fight deceptive mortgage ads

In press releases yesterday, here and here, the Federal Trade Commission and the Consumer Financial Protection Bureau announced that they are teaming up to fight deceptive mortgage advertising. The FTC sent warning letters to 20 real estate agents, home builders, and lead generators, urging them to review their advertisements for compliance with the Mortgage Acts […]

Supreme Court ERISA Case Could Affect the Viability of Personal-Injury Suits

By Brian Wolfman I'm writing about U.S. Airways v. McCutchen, an ERISA case set for argument in the U.S. Supreme Court on November 27. The case's outcome may affect the viability of some personal-injury suits. When people are harmed by consumer products, doctors' negligence, or in car crashes, for instance, they often incur medical expenses. […]

Does the Federal Government’s $4.5 BIllion Settlement of Criminal Charges Against BP Do Enough to Deter and Punish?

Does BP's settlement of criminal charges with the federal government do enough to deter and punish? Law professors talk about that question in this video, with one calling it "a drop in the bucket" given BP's deep pockets, the extent of the wrong doing, and the death and destruction caused by the BP spill in the […]